Table 3.
Novel agents investigated in lower-risk MDS
RBC indicates red blood cell; TGF, transforming growth factor; SAA, severe aplastic anemia; HI, hematologic improvement; and IWG, International working group.
Novel agents investigated in lower-risk MDS
RBC indicates red blood cell; TGF, transforming growth factor; SAA, severe aplastic anemia; HI, hematologic improvement; and IWG, International working group.
